Latest Insider Transactions at Cme Group Inc. (CME)
This section provides a real-time view of insider transactions for Cme Group Inc. (CME). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CME GROUP INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CME GROUP INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 25
2024
|
Daniel R Glickman Director |
BUY
Grant, award, or other acquisition
|
Direct |
748
+4.82%
|
$145,112
$194.1 P/Share
|
|
Jun 25
2024
|
Robert J Tierney Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
748
+5.38%
|
$145,112
$194.1 P/Share
|
|
Jun 25
2024
|
William R Shepard Director |
BUY
Grant, award, or other acquisition
|
Indirect |
1,237
+0.48%
|
$239,978
$194.1 P/Share
|
|
Jun 25
2024
|
William R Shepard Director |
BUY
Open market or private purchase
|
Indirect |
312
+0.12%
|
$60,840
$195.07 P/Share
|
|
Jun 25
2024
|
William R Shepard Director |
BUY
Open market or private purchase
|
Direct |
13
+0.55%
|
$2,535
$195.07 P/Share
|
|
Jun 25
2024
|
Patrick W Maloney Director |
BUY
Grant, award, or other acquisition
|
Direct |
748
+17.34%
|
$145,112
$194.1 P/Share
|
|
Jun 25
2024
|
Harold Eugene Ford Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
748
+32.42%
|
$145,112
$194.1 P/Share
|
|
Jun 13
2024
|
Charles P Carey Director |
SELL
Open market or private sale
|
Indirect |
3,000
-29.52%
|
$585,000
$195.44 P/Share
|
|
Jun 06
2024
|
Daniel R Glickman Director |
SELL
Open market or private sale
|
Direct |
650
-4.43%
|
$130,650
$201.44 P/Share
|
|
May 20
2024
|
Elizabeth A Cook Director |
SELL
Open market or private sale
|
Indirect |
1,000
-5.2%
|
$211,000
$211.52 P/Share
|
|
May 14
2024
|
Derek Sammann Sr MD Gl Hd Commodity & Option |
BUY
Bona fide gift
|
Indirect |
3,789
+25.95%
|
-
|
|
May 14
2024
|
Derek Sammann Sr MD Gl Hd Commodity & Option |
SELL
Bona fide gift
|
Direct |
3,789
-28.1%
|
-
|
|
May 13
2024
|
Terry L Savage Director |
SELL
Open market or private sale
|
Indirect |
2,500
-12.54%
|
$525,000
$210.65 P/Share
|
|
May 08
2024
|
Hilda Harris Piell Sr MD & Chief HR Officer |
SELL
Open market or private sale
|
Direct |
7,140
-5.22%
|
$1,499,400
$210.37 P/Share
|
|
Apr 29
2024
|
Terrence A Duffy Chairman and CEO |
SELL
Open market or private sale
|
Direct |
40,000
-13.79%
|
$8,400,000
$210.39 P/Share
|
|
Mar 26
2024
|
William R Shepard Director |
BUY
Open market or private purchase
|
Indirect |
282
+0.11%
|
$60,348
$214.71 P/Share
|
|
Mar 26
2024
|
William R Shepard Director |
BUY
Open market or private purchase
|
Direct |
12
+0.51%
|
$2,568
$214.71 P/Share
|
|
Mar 15
2024
|
Timothy Francis Mc Court Sr MD Global Head Equity & FX |
SELL
Payment of exercise price or tax liability
|
Direct |
383
-2.82%
|
$83,111
$217.5 P/Share
|
|
Mar 15
2024
|
Timothy Francis Mc Court Sr MD Global Head Equity & FX |
BUY
Open market or private sale
|
Direct |
556
+7.49%
|
$120,652
$217.5 P/Share
|
|
Mar 15
2024
|
Ken Vroman Chief Transformation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,449
-5.49%
|
$531,433
$217.5 P/Share
|
|
Mar 15
2024
|
Ken Vroman Chief Transformation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,292
+19.09%
|
$1,148,364
$217.5 P/Share
|
|
Mar 15
2024
|
Lynne Fitzpatrick Sr MD Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
329
-1.15%
|
$71,393
$217.5 P/Share
|
|
Mar 15
2024
|
Lynne Fitzpatrick Sr MD Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
559
+3.75%
|
$121,303
$217.5 P/Share
|
|
Mar 15
2024
|
Derek Sammann Sr MD Gl Hd Commodity & Option |
SELL
Payment of exercise price or tax liability
|
Direct |
3,014
-18.27%
|
$654,038
$217.5 P/Share
|
|
Mar 15
2024
|
Derek Sammann Sr MD Gl Hd Commodity & Option |
BUY
Grant, award, or other acquisition
|
Direct |
6,803
+29.2%
|
$1,476,251
$217.5 P/Share
|
|
Mar 15
2024
|
Suzanne Sprague Sr MD Global Head of Clearing |
SELL
Payment of exercise price or tax liability
|
Direct |
330
-2.21%
|
$71,610
$217.5 P/Share
|
|
Mar 15
2024
|
Suzanne Sprague Sr MD Global Head of Clearing |
BUY
Grant, award, or other acquisition
|
Direct |
561
+6.93%
|
$121,737
$217.5 P/Share
|
|
Mar 15
2024
|
Jack J Tobin MD Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
638
-1.36%
|
$138,446
$217.5 P/Share
|
|
Mar 15
2024
|
Jack J Tobin MD Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
541
+2.24%
|
$117,397
$217.5 P/Share
|
|
Mar 15
2024
|
Sunil Cutinho Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,183
-9.74%
|
$690,711
$217.5 P/Share
|
|
Mar 15
2024
|
Sunil Cutinho Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,183
+18.02%
|
$1,558,711
$217.5 P/Share
|
|
Mar 15
2024
|
Hilda Harris Piell Sr MD & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,603
-6.67%
|
$564,851
$217.5 P/Share
|
|
Mar 15
2024
|
Hilda Harris Piell Sr MD & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,047
+13.42%
|
$1,312,199
$217.5 P/Share
|
|
Mar 15
2024
|
Julie Winkler Sr MD Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,847
-8.33%
|
$617,799
$217.5 P/Share
|
|
Mar 15
2024
|
Julie Winkler Sr MD Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,425
+15.82%
|
$1,394,225
$217.5 P/Share
|
|
Mar 15
2024
|
Terrence A Duffy Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
20,095
-15.75%
|
$4,360,615
$217.5 P/Share
|
|
Mar 15
2024
|
Terrence A Duffy Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
45,359
+26.23%
|
$9,842,903
$217.5 P/Share
|
|
Mar 15
2024
|
Jonathan L Marcus Sr MD General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
282
-5.45%
|
$61,194
$217.5 P/Share
|
|
Mar 15
2024
|
Julie Holzrichter Sr MD Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,350
-8.02%
|
$726,950
$217.5 P/Share
|
|
Mar 15
2024
|
Julie Holzrichter Sr MD Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,560
+15.33%
|
$1,640,520
$217.5 P/Share
|
|
Mar 07
2024
|
Jack J Tobin MD Chief Accounting Officer |
SELL
Bona fide gift
|
Direct |
72
-0.31%
|
-
|
|
Jan 31
2024
|
Timothy Francis Mc Court Sr MD Global Head Equity & FX |
SELL
Open market or private sale
|
Direct |
35
-0.54%
|
$7,210
$206.78 P/Share
|
|
Jan 18
2024
|
William R Shepard Director |
BUY
Open market or private purchase
|
Indirect |
1,331
+0.52%
|
$268,862
$202.44 P/Share
|
|
Jan 18
2024
|
William R Shepard Director |
BUY
Open market or private purchase
|
Direct |
58
+2.44%
|
$11,716
$202.44 P/Share
|
|
Dec 31
2023
|
Terrence A Duffy Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,366
-13.08%
|
$2,596,860
$210.6 P/Share
|
|
Dec 28
2023
|
William R Shepard Director |
BUY
Open market or private purchase
|
Indirect |
266
+0.11%
|
$55,860
$210.79 P/Share
|
|
Dec 28
2023
|
William R Shepard Director |
BUY
Open market or private purchase
|
Direct |
11
+0.48%
|
$2,310
$210.79 P/Share
|
|
Dec 11
2023
|
Bryan T Durkin Director |
SELL
Open market or private sale
|
Direct |
5,560
-8.18%
|
$1,200,960
$216.37 P/Share
|
|
Dec 04
2023
|
Derek Sammann Sr MD Gl Hd Commodity & Option |
SELL
Open market or private sale
|
Indirect |
1,862
-100.0%
|
$413,364
$222.07 P/Share
|
|
Dec 01
2023
|
Derek Sammann Sr MD Gl Hd Commodity & Option |
SELL
Open market or private sale
|
Indirect |
10,681
-45.73%
|
$2,349,820
$220.5 P/Share
|